CHYMF(CHYMF)
CHYMF
No analyst ratings available
No analyst price targets available for CHYMF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.22B | $1.32B | $1.32B |
| Low | $1.21B | $1.28B | $1.29B |
| High | $1.23B | $1.36B | $1.34B |
| EBITDA Avg | $315M | $344M | $371M |
| Low | $310M | $339M | $366M |
| High | $319M | $348M | $376M |
| EBIT Avg | $226M | $245M | $264M |
| Low | $222M | $240M | $259M |
| High | $230M | $250M | $269M |
| Net Income Avg | $109M | $122M | $136M |
| Low | $106M | $119M | $132M |
| High | $112M | $125M | $139M |
| EPS Avg | $0.10 | $0.11 | $0.13 |
| Low | $0.10 | $0.11 | $0.12 |
| High | $0.10 | $0.12 | $0.13 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |